1188265-55-5
1188265-55-5
Chemical Structure
(Rac)-Verapamil-d7 (hydrochloride)
- CAS No.: 1188265-55-5
- Formula:C27H32D7ClN2O4
- Molecular Weight:498.11
IUPAC Name: 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-(propan-2-yl-d7)pentanenitrile hydrochloride
InChIKey: DOQPXTMNIUCOSY-OMVHPOPLSA-N
SMILES: COC(C=C1CCN(C)CCCC(C#N)(C2=CC(OC)=C(C=C2)OC)C(C([2H])([2H])[2H])([2H])C([2H])([2H])[2H])=C(C=C1)OC.Cl
Biological Activity: (Rac)-Verapamil-d7 (hydrochloride) is the deuterium labeled (Rac)-Verapamil[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-Verapamil-d7 (hydrochloride) | 99.66% | (Rac)-Verapamil-d7 (hydrochloride) is the deuterium labeled (Rac)-Verapamil. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Verapamil (Standard) | 99.72% | Verapamil (Standard) is the analytical standard of Verapamil. This product is intended for research and analytical applications. Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Verapamil-d3 | Verapamil-d3 ((±)-Verapamil-d3) is deuterium labeled Verapamil. Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Verapamil-d6 | Verapamil-d6 ((±)-Verapamil-d6) is deuterium labeled Verapamil. Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Verapamil-d7 | Verapamil-d7 is the deuterium labeled Verapamil (HY-14275). Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Verapamil | 99.88% | Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
